Skip to main content

Table 4 Phenotype of DC-Tuper stimulated lymphocytes

From: Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

Phenotype (%) Donor Breast cancer
  NSL NSL + DC-Tuper NSL NSL + DC-Tuper
CD3+CD56- 73 ± 30 76 ± 24 75 ± 17 73 ± 15
CD3-CD56+ 6 + 8 5 ± 6 10 ± 13 5 ± 5
CD3+CD56+ 18 ± 21 18 ± 18 11 ± 5 20 ± 13
CD4+ T cell 28 ± 30 24 ± 27 29 ± 21 31 ± 22
CD8+ T cell 51 ± 21 57 ± 18 51 ± 19 59 ± 18
TCR α/β 75 ± 23 77 ± 23 70 ± 20 83 ± 12
TCR γ/δ 14 ± 15 13 ± 18 14 ± 11 11 ± 12
  1. Cells are from healthy donors (n = 3) or breast cancer patients (n = 6). The percentage of positive cells for lymphocyte markers was measured in a 99% CD45+ population. Data are expressed as mean ± standard deviation. DC-Tu, dendritic cells pulsed with treated tumour cells; NSL, nonstimulated lymphocytes.